Stryker (SYK) Stock Price, News & Analysis

+1.94 (+0.58%)
(As of 05:45 PM ET)
Today's Range
50-Day Range
52-Week Range
1.52 million shs
Average Volume
1.28 million shs
Market Capitalization
$128.16 billion
P/E Ratio
Dividend Yield
Price Target

Stryker MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.77 Rating Score
1.1% Upside
$340.67 Price Target
Short Interest
1.19% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.63mentions of Stryker in the last 14 days
Based on 17 Articles This Week
Insider Trading
Selling Shares
$72.85 M Sold Last Quarter
Proj. Earnings Growth
From $11.86 to $13.24 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.79 out of 5 stars

Medical Sector

46th out of 909 stocks

Surgical & Medical Instruments Industry

8th out of 96 stocks

SYK stock logo

About Stryker Stock (NYSE:SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

SYK Stock Price History

SYK Stock News Headlines

Pentagon contract could send this $2 AI stock soaring
Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...
Stryker (SYK) Set to Announce Quarterly Earnings on Tuesday
Stryker Unusual Options Activity For April 19
Pentagon contract could send this $2 AI stock soaring
Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...
Stryker Stock Boosted by Big Money Investors
Stryker: A Great Company At An Expensive Price
Price Over Earnings Overview: Stryker
Stryker announces Annual Meeting of Shareholders
Top Stock Reports for Disney, Morgan Stanley & Stryker
See More Headlines
Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/31 Dividend
Last Earnings
Dividend Payable
Ex-Dividend for 4/30 Dividend
Dividend Payable
Next Earnings (Confirmed)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Equipment
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
13 Analysts


Net Income
$3.17 billion
Pretax Margin


Sales & Book Value

Annual Sales
$20.50 billion
Cash Flow
$13.78 per share
Book Value
$48.94 per share


Free Float
Market Cap
$128.16 billion

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Should I Buy Stryker Stock? SYK Pros and Cons Explained


Here are some ways that investors could benefit from investing in Stryker Co.:

  • Stryker Co. has shown consistent growth in its stock price, with a current value of $350.19, indicating a strong performance in the market.
  • The company operates in the surgical & medical instruments industry, which is known for steady demand and innovation, providing long-term growth potential.
  • Stryker's diversified product portfolio, including orthopaedic implants, surgical equipment, and neurotechnology products, positions it well in multiple healthcare segments.
  • Strong financial backing from institutional investors like Vanguard Group Inc., BlackRock Inc., and State Street Corp. indicates confidence in the company's future prospects.
  • Recent quarterly earnings data released by Stryker on January 30th showed positive results, reflecting the company's ability to generate revenue and profitability.


Investors should be bearish about investing in Stryker Co. for these reasons:

  • While Stryker has a strong market presence, competition in the healthcare equipment industry is intense, leading to potential pricing pressures and market share challenges.
  • The company's stock has a relatively high price-to-earnings ratio of 42.45, which may indicate that the stock is currently overvalued compared to its earnings potential.
  • As a medical technology company, Stryker is subject to regulatory risks and changes in healthcare policies, which could impact its operations and financial performance.
  • The company's debt-to-equity ratio of 0.59 suggests a moderate level of financial leverage, which could pose risks in times of economic downturns or rising interest rates.
  • Investors should consider market volatility and economic uncertainties that could affect Stryker's stock price and overall performance in the future.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, April 13, 2024. Please send any questions or comments about these Stryker pros and cons to contact@marketbeat.com.

SYK Stock Analysis - Frequently Asked Questions

Should I buy or sell Stryker stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SYK shares.
View SYK analyst ratings
or view top-rated stocks.

What is Stryker's stock price target for 2024?

13 brokers have issued 1-year price objectives for Stryker's shares. Their SYK share price targets range from $292.00 to $406.00. On average, they predict the company's share price to reach $340.67 in the next twelve months. This suggests a possible upside of 1.1% from the stock's current price.
View analysts price targets for SYK
or view top-rated stocks among Wall Street analysts.

How have SYK shares performed in 2024?

Stryker's stock was trading at $299.46 at the beginning of the year. Since then, SYK stock has increased by 12.5% and is now trading at $336.85.
View the best growth stocks for 2024 here

When is Stryker's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 30th 2024.
View our SYK earnings forecast

How can I listen to Stryker's earnings call?

Stryker will be holding an earnings conference call on Tuesday, April 30th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) announced its quarterly earnings data on Tuesday, January, 30th. The medical technology company reported $3.46 earnings per share for the quarter, beating analysts' consensus estimates of $3.27 by $0.19. The medical technology company had revenue of $5.82 billion for the quarter, compared to analysts' expectations of $5.60 billion. Stryker had a trailing twelve-month return on equity of 22.99% and a net margin of 15.44%. The company's revenue for the quarter was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.00 earnings per share.
Read the conference call transcript

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker declared a quarterly dividend on Wednesday, February 7th. Stockholders of record on Friday, March 29th will be paid a dividend of $0.80 per share on Tuesday, April 30th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date of this dividend is Wednesday, March 27th.
Read our dividend analysis for SYK

Is Stryker a good dividend stock?

Stryker (NYSE:SYK) pays an annual dividend of $3.20 per share and currently has a dividend yield of 0.98%. The company has been increasing its dividend for 31 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 38.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SYK will have a dividend payout ratio of 24.17% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SYK.

What guidance has Stryker issued on next quarter's earnings?

Stryker updated its FY 2024 earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of 11.700-12.000 for the period, compared to the consensus EPS estimate of 11.560. The company issued revenue guidance of -.

What is Kevin A. Lobo's approval rating as Stryker's CEO?

1,492 employees have rated Stryker Chief Executive Officer Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among the company's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

Who are Stryker's major shareholders?

Stryker's stock is owned by a variety of institutional and retail investors. Top institutional investors include Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.32%), Sumitomo Mitsui Trust Holdings Inc. (0.31%), Global Assets Advisory LLC (0.25%), Raymond James & Associates (0.16%), Los Angeles Capital Management LLC (0.10%) and Confluence Investment Management LLC (0.07%). Insiders that own company stock include Allan C Golston, Glenn S Boehnlein, James Andrew Pierce, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Ronda E Stryker, Srikant M Datar, Viju Menon and William E Berry Jr.
View institutional ownership trends

How do I buy shares of Stryker?

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Stryker have any subsidiaries?
The following companies are subsidiares of Stryker: 2Hip Holdings SAS, ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc., Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, BioMimetic Therapeutics LLC, BioMimetic Therapeutics USA Inc., CHG Hospital Beds, Cactus LLC, Cardan Robotics, Cartiva Inc., Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, EnMovi Ltd., Entellus Medical, Entellus Medical Inc., GYS Tech LLC, Gauss Surgical, Gauss Surgical Inc., Gauss Surgical Singapore Pte. Ltd., Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Medical Technologies Inc., HyperBranch Medical Technology, Image Guided Technologies, Imascap SAS, Imorphics Limited, Infinity MSD Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Inc., K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, Ortho-Space Ltd., OrthoHelix Surgical Designs Inc., OrthoSensor, OrthoSensor Korea Ltd, OrthoSpace, OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthosensor Inc., Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, PTH West LLC, Patient Safety Technologies, Patton Surgical, Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Inc., Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Pivot Medical, PlasmaSol, Porex Technologies, SCI Calyx SA, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions B.V., Stryker Asia Holdings C.V., Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold B.V., Stryker Beteiligungs GmbH, Stryker Canada Holding Company ULC, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Capital B.V., Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services B.V., Stryker Employment Company LLC, Stryker European Holdings Coöperatief U.A, Stryker European Holdings LLC, Stryker European Operations B.V., Stryker European Operations Holdings I B.V., Stryker European Operations Holdings II B.V., Stryker European Operations Holdings III B.V., Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France SAS, Stryker Funding B.V., Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings B.V., Stryker IFSC Designated Activity Company, Stryker Iberia S.L. Unipersonal, Stryker India Private Limited, Stryker International Acquisitions B.V., Stryker International Holdings B.V., Stryker Ireland Limited, Stryker Italia S.r.l., Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Sarl, Stryker Malta Holdings Limited, Stryker Manufacturing Holdings B.V., Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland B.V., Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Poland Services sp. z o.o., Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Holdings B.V., Stryker Puerto Rico LLC, Stryker Puerto Rico Sales LLC, Stryker Renovation Services LLC, Stryker Romania SRL, Stryker Sales LLC, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Tijuana Operations S. de R.L. de C.V., Stryker Trauma GmbH, Stryker Turkish Holdings B.V., Stryker UK Limited, Stryker Unite Ltd., Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TMG France SAS, TMJ Solutions LLC, TSO3 Corporation, TSO3 Inc., Thermedx LLC, Tornier Inc., Tornier Orthopedics Ireland Limited, Tornier Pty Ltd., Tornier SAS, Tornier Scandinavia A/S, Tornier UK Limited, Tornier US Holdings Inc., Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (B.V.I.) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, Trooper Holdings Inc., Vexim, Vocera, Vocera Communications, Wright DutchCo B.V., Wright Medical Australia Pty Limited, Wright Medical Brasil Ltda, Wright Medical Costa Rica S.A., Wright Medical Device (Shanghai) Co. Ltd., Wright Medical Group, Wright Medical Group Inc., Wright Medical Netherlands B.V., Wright Medical Singapore Pte Ltd, Wright Medical Technology Inc., Wright Medical UK Ltd, Wright PacRim Inc., ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.
Read More
This page (NYSE:SYK) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners